Morepen Laboratories

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue339.51371.18384.10398.29396.59
Expenses326.57349.47356.76351.06343.88
EBITDA18.1126.8932.6054.7860.12
EBIT13.5021.9927.7849.2653.44
Profit Before Tax12.9521.7127.3347.2252.71
Net Profit10.2815.8519.9235.2039.96
Financial Ratios
Operating Profit Margin5.38%7.29%8.55%13.88%15.31%
Net Profit Margin3.05%4.29%5.22%8.92%10.18%
Earning Per Share (Diluted)0.200.310.390.690.78
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.0.4
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ